VRTX
Vertex Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
4.14 / 10Overall Score
NeturalInvestment Rating
4.14 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of VRTX
- Based on a composite score of 4.14/10, we rate VRTX as a Netural. Our analysis breaks down into 3.24/10 for Fundamentals, 2.70/10 for Technicals, and 5.32/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of VRTX?
Is VRTX undervalued or overvalued?
Is money flowing into or out of VRTX?
Trend Analysis of VRTX
- Based on a composite score of 4.14/10, we rate VRTX as a Netural. Our analysis breaks down into 3.24/10 for Fundamentals, 2.70/10 for Technicals, and 5.32/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is VRTX undervalued or overvalued?
Technical Analysis of VRTX?
Is money flowing into or out of VRTX?
